248 related articles for article (PubMed ID: 27935554)
1. Risk of Mortality Associated with Antipsychotic Monotherapy and Polypharmacy Among Community-Dwelling Persons with Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Alzheimers Dis; 2017; 56(1):107-118. PubMed ID: 27935554
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic polypharmacy among a nationwide sample of community-dwelling persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
J Alzheimers Dis; 2014; 41(4):1223-8. PubMed ID: 24787914
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
[TBL] [Abstract][Full Text] [Related]
4. The Risk of Head Injuries Associated With Antipsychotic Use Among Persons With Alzheimer's disease.
Tapiainen V; Lavikainen P; Koponen M; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Am Geriatr Soc; 2020 Mar; 68(3):595-602. PubMed ID: 31912482
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of antipsychotics among community-dwelling persons with Alzheimer׳s disease: A nationwide register-based study.
Koponen M; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Ahonen R; Hartikainen S
Eur Neuropsychopharmacol; 2015 Oct; 25(10):1706-13. PubMed ID: 26233607
[TBL] [Abstract][Full Text] [Related]
6. Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer's disease: a nationwide matched cohort study.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Tolppanen AM
Alzheimers Res Ther; 2017 Aug; 9(1):59. PubMed ID: 28764750
[TBL] [Abstract][Full Text] [Related]
7. Drug use in persons with and without Alzheimer's disease aged 90 years or more.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Age Ageing; 2016 Nov; 45(6):900-904. PubMed ID: 27609205
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic drugs use and psychotropic polypharmacy among persons with Alzheimer's disease.
Orsel K; Taipale H; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Gardarsdottir H; Hartikainen S
Eur Neuropsychopharmacol; 2018 Nov; 28(11):1260-1269. PubMed ID: 30153953
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer's Disease.
Koponen M; Rajamaki B; Lavikainen P; Bell JS; Taipale H; Tanskanen A; Hartikainen S; Tolppanen AM
J Am Med Dir Assoc; 2022 Jun; 23(6):1059-1065.e4. PubMed ID: 34717887
[TBL] [Abstract][Full Text] [Related]
10. Impact of opioid initiation on antipsychotic and benzodiazepine and related drug use among persons with Alzheimer's disease.
Hamina A; Lavikainen P; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Taipale H
Int Psychogeriatr; 2018 Jul; 30(7):947-956. PubMed ID: 29559009
[TBL] [Abstract][Full Text] [Related]
11. Hospital-Treated Pneumonia Associated with Opioid Use Among Community Dwellers with Alzheimer's Disease.
Hamina A; Taipale H; Karttunen N; Tanskanen A; Tiihonen J; Tolppanen AM; Hartikainen S
J Alzheimers Dis; 2019; 69(3):807-816. PubMed ID: 31127778
[TBL] [Abstract][Full Text] [Related]
12. Use of benzodiazepines and related drugs is associated with a risk of stroke among persons with Alzheimer's disease.
Taipale H; Koponen M; Tanskanen A; Lavikainen P; Tolppanen AM; Sund R; Tiihonen J; Hartikainen S
Int Clin Psychopharmacol; 2017 May; 32(3):135-141. PubMed ID: 28072593
[TBL] [Abstract][Full Text] [Related]
13. Does Recent Hospitalization Increase Antipsychotic Initiation Among Community Dwellers With Alzheimer's Disease?
Hakala A; Tolppanen AM; Koponen M; Taipale H; Tanskanen A; Hartikainen S; Tiihonen M
J Am Med Dir Assoc; 2021 Jul; 22(7):1543-1547.e3. PubMed ID: 33460619
[TBL] [Abstract][Full Text] [Related]
14. Antiepileptic Drug Use Is Associated with an Increased Risk of Pneumonia Among Community-Dwelling Persons with Alzheimer's Disease-Matched Cohort Study.
Taipale H; Lampela P; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Tolppanen AM
J Alzheimers Dis; 2019; 68(1):127-136. PubMed ID: 30775987
[TBL] [Abstract][Full Text] [Related]
15. Risk of death associated with new benzodiazepine use among persons with Alzheimer disease: A matched cohort study.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2018 Apr; 33(4):583-590. PubMed ID: 29143367
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic use and mortality risk in community-dwelling Alzheimer's disease patients: evidence for a role of dementia severity.
Gardette V; Lapeyre-Mestre M; Coley N; Cantet C; Montastruc JL; Vellas B; Andrieu S
Curr Alzheimer Res; 2012 Nov; 9(9):1106-16. PubMed ID: 22950915
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic Use and Risk of Hospitalization or Death Due to Pneumonia in Persons With and Those Without Alzheimer Disease.
Tolppanen AM; Koponen M; Tanskanen A; Lavikainen P; Sund R; Tiihonen J; Hartikainen S; Taipale H
Chest; 2016 Dec; 150(6):1233-1241. PubMed ID: 27298071
[TBL] [Abstract][Full Text] [Related]
18. Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland.
Laitinen ML; Bell JS; Lavikainen P; Lönnroos E; Sulkava R; Hartikainen S
Int Psychogeriatr; 2011 Dec; 23(10):1623-31. PubMed ID: 21867581
[TBL] [Abstract][Full Text] [Related]
19. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.
Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
BMC Geriatr; 2016 Dec; 16(1):204. PubMed ID: 27908278
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of psychotropic drug use among persons with and without Alzheimer's disease in Finnish nationwide cohort.
Taipale H; Koponen M; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S
Eur Neuropsychopharmacol; 2014 Nov; 24(11):1729-37. PubMed ID: 25453487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
